Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543)

Affiliations

¹ Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics & Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Leonard Davis Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
² Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: nieraj.jain@emory.edu.

Comment

Brian L VanderBeek et al. Ophthalmology. 2020 May.

. 2020 May;127(5):e35-e36.

doi: 10.1016/j.ophtha.2020.01.004.

¹ Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics & Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Leonard Davis Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
² Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: nieraj.jain@emory.edu.

No abstract available

Comment in

Reply.
Ludwig CA, Vail D, Moshfeghi DM. Ludwig CA, et al. Ophthalmology. 2020 May;127(5):e36. doi: 10.1016/j.ophtha.2020.01.005. Ophthalmology. 2020. PMID: 32327144 No abstract available.

Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States.
Ludwig CA, Vail D, Callaway NF, Pasricha MV, Moshfeghi DM. Ludwig CA, et al. Ophthalmology. 2020 Apr;127(4):535-543. doi: 10.1016/j.ophtha.2019.10.036. Epub 2019 Nov 5. Ophthalmology. 2020. PMID: 31899034